Related Experiment Videos

IgE-mediated 14C-serotonin release from rat mast cells modulated by morphine and endorphins

Life Sciences
|August 2, 1982
PubMed

Insights

Prostaglandin E1 (PGE1) inhibits mediator release from rat mast cells. Morphine and endorphins reversed this effect, suggesting opioid receptors modulate immune responses.

Area of Science:

  • Immunology
  • Pharmacology
  • Neuroscience

Background:

  • Prostaglandin E1 (PGE1) plays a role in modulating immune responses.
  • Opioid compounds like morphine and endorphins are known to interact with cellular signaling pathways.

Purpose of the Study:

  • To investigate the interaction between PGE1, morphine, beta-endorphin, and Met-enkephalin on rat mast cells.
  • To determine the effect of these substances on immunoglobulin E (IgE)-mediated 14C-serotonin release.

Main Methods:

  • Formaldehyde method utilized for examining cellular interactions.
  • Measurement of 14C-serotonin release from rat mast cells following antigen challenge.
  • Dose-response and antagonism studies using morphine, beta-endorphin, Met-enkephalin, and naloxone.

Main Results:

  • PGE1 demonstrated a dose-related inhibition of mediator release.
  • Morphine reversed the inhibitory effect of PGE1 in a dose-dependent and stereospecific manner.
  • Beta-endorphin and Met-enkephalin mimicked the action of morphine and were antagonized by naloxone.

Conclusions:

  • Morphine and endorphins modulate immunological mediator release from rat mast cells.
  • These modulatory effects appear to be mediated through opioid receptors.

Related Concept Videos